NU576 Unit 4 Seminar Notes: Contraception & Unintended Pregnancy Insights

Student Name

Purdue University Globle 

NU576 NP II – Primary Care of Women’s Health

Prof. Name

Date

Understanding Contraception and Unintended Pregnancy Prevention

Contraception plays a significant role in preventing unintended pregnancies and supporting reproductive health across diverse populations. A patient-centered approach allows healthcare providers to help individuals select methods that fit their unique circumstances, including medical history, cultural considerations, relationship status, and long-term pregnancy intentions.

Modern contraceptive counseling emphasizes shared decision-making. During clinical visits, providers should create a confidential and supportive environment where patients feel comfortable discussing whether they wish to become pregnant now, later, or not at all. This approach improves patient satisfaction and increases adherence to the selected contraceptive method.

Healthcare professionals should also use contraceptive appointments to address preventive care needs and discuss reproductive life planning.

Key Components of Contraceptive Counseling

A comprehensive contraceptive consultation should include:

• Assessment of pregnancy intentions.

• Review of health history and risk factors.

• Discussion of contraceptive effectiveness.

• Counseling on side effects and menstrual changes.

• Evaluation of privacy and confidentiality concerns.

• Guidance on future fertility expectations.

• Recommendations for age-appropriate preventive screenings.

• Review of state and local regulations regarding contraceptive access, including prescribing considerations for minors.

Patients planning future pregnancies should receive preconception counseling and begin prenatal vitamins containing folic acid before conception to reduce the risk of neural tube defects.

Factors to Consider When Choosing a Birth Control Method

Selecting the most appropriate contraceptive method requires individualized care. Providers should explain how each option works and discuss its advantages and limitations.

Important considerations include:

• Method administration (pill, injection, implant, patch, ring, or intrauterine device).

• Frequency of use.

• Pregnancy prevention effectiveness.

• Effects on menstrual bleeding patterns.

• Potential adverse effects.

• Non-contraceptive health benefits.

• Impact on future fertility.

• Personal lifestyle and privacy preferences.

Ultimately, the patient’s informed preference should guide contraceptive selection.

Combined Estrogen-Progestin Contraceptives

Combined hormonal contraceptives contain both estrogen and progestin and are available as:

• Oral contraceptive pills.

• Transdermal patches.

• Vaginal rings.

These methods are highly effective when used correctly and offer several health benefits beyond pregnancy prevention.

Benefits of Combined Hormonal Contraceptives

Combined estrogen-progestin methods may provide:

• Reduced menstrual cramps.

• Improved symptoms of endometriosis.

• Decreased heavy menstrual bleeding.

• More predictable menstrual cycles.

• Relief from premenstrual syndrome (PMS).

• Lower risk of ovarian and endometrial cancers.

• Reduced formation of ovarian cysts.

• Lower risk of ectopic pregnancy.

• Improvement in acne and hirsutism.

• Reduced incidence of benign breast disease.

The estrogen dose may influence bleeding patterns. Lower-dose formulations often result in lighter periods, while higher doses are more likely to maintain regular withdrawal bleeding.

Screening Before Prescribing Estrogen-Containing Contraceptives

Before initiating estrogen-containing methods, providers should evaluate patients for conditions that may increase complications.

Screening should include assessment for:

• Migraine headaches, especially migraine with aura.

• Liver disease.

• Personal or family history of blood clots.

• Smoking status.

• Cardiovascular disease.

• Additional thromboembolic risk factors.

These evaluations are essential to ensure patient safety and align with current contraceptive prescribing guidelines.

Progestin-Only Contraceptive Methods

Progestin-only contraception is an excellent option for individuals who cannot use estrogen-containing products or prefer hormone regimens without estrogen exposure.

Available options include:

• Depot medroxyprogesterone acetate (DMPA) injections.

• Etonogestrel implants.

• Progestin-only pills.

Depo-Provera (DMPA) Injection

Depot medroxyprogesterone acetate is administered every 12 weeks and provides reliable pregnancy prevention.

Benefits include:

• Reduced menstrual bleeding.

• Improved dysmenorrhea.

• Reduced risk of endometrial cancer.

Potential considerations include:

• Weight gain.

• Decreased bone mineral density with prolonged use.

• Increased risk of osteopenia or osteoporosis in susceptible individuals.

Patients receiving DMPA should be counseled about maintaining adequate calcium and vitamin D intake and adopting bone-healthy lifestyle practices.

Nexplanon Implant

The etonogestrel implant is a long-acting reversible contraceptive (LARC) placed subdermally in the upper arm.

Key advantages include:

• Greater than 99% effectiveness.

• Long-term pregnancy prevention.

• Rapid return of fertility following removal.

Some individuals may experience irregular bleeding or persistent spotting, particularly during the first several months after insertion.

Progestin-Only Pills

Progestin-only pills are particularly useful for breastfeeding individuals and those with contraindications to estrogen.

Important counseling points include:

• Daily administration at the same time.

• Reduced effectiveness with delayed or missed doses.

• Possible breakthrough bleeding.

These medications offer an estrogen-free alternative while maintaining favorable contraceptive efficacy when used consistently.

Intrauterine Devices (IUDs)

Intrauterine devices remain among the most effective reversible contraceptive options available worldwide.

Non-Hormonal Copper IUD

The copper IUD provides long-term, hormone-free contraception and may remain effective for several years depending on the device.

Patients should be informed about potential side effects, including:

• Increased menstrual bleeding.

• Longer menstrual periods.

• Increased cramping, especially during the initial months after placement.

Hormonal IUD

Hormonal IUDs release levonorgestrel and provide highly effective contraception with additional menstrual benefits.

Common outcomes include:

• Initial spotting.

• Progressively lighter periods.

• Amenorrhea in some users.

Many patients prefer hormonal IUDs because they combine convenience, long-term effectiveness, and reduced menstrual bleeding.

Special Considerations for Specific Populations

Contraceptive counseling should be tailored to meet the needs of diverse patient populations.

Adolescents

Adolescents benefit from confidential and developmentally appropriate counseling. Providers should remain familiar with regional laws governing consent and contraceptive access to ensure legally compliant care.

Postpartum Patients

Postpartum contraceptive planning is essential to optimize birth spacing and maternal health outcomes. While the six-week postpartum visit is a common time to discuss contraception, many methods can be initiated immediately after delivery depending on breastfeeding status and individual medical considerations.

Postabortion Patients

Patients who desire pregnancy prevention following abortion can often begin contraception immediately, helping reduce the likelihood of unintended subsequent pregnancies.

Patients With Chronic Health Conditions

Individuals with chronic medical conditions require individualized contraceptive recommendations based on established clinical guidelines, including the CDC’s Medical Eligibility Criteria for Contraceptive Use.

Special considerations may apply to patients with:

• Obesity.

• Substance use disorders.

• Cancer histories.

• Intellectual or developmental disabilities.

• Cardiovascular disease.

Preventive Counseling During Contraceptive Visits

Contraceptive appointments provide valuable opportunities to address broader aspects of preventive healthcare.

Topics may include:

• Sexually transmitted infection (STI) screening.

• Safer sex practices.

• Pregnancy planning.

• Immunization updates.

• Routine health screenings.

• Individual reproductive goals.

Because most contraceptive methods do not protect against STIs, healthcare providers should discuss condom use and other barrier methods when appropriate.

Selecting Birth Control Based on Patient Goals

The ideal contraceptive method should align with the patient’s health needs and desired outcomes. For example, individuals seeking acne improvement and lighter menstrual periods may benefit from combined oral contraceptives containing drospirenone and ethinyl estradiol, such as Yaz, provided no contraindications exist.

Patients commonly prioritize goals such as:

• Improved acne control.

• Reduced menstrual bleeding.

• Avoidance of weight gain.

• Long-term contraception.

• Rapid return to fertility.

• Enhanced privacy and convenience.

Shared decision-making remains the cornerstone of effective contraceptive care and contributes to improved reproductive health outcomes worldwide.

References

American College of Obstetricians and Gynecologists. (2024). Long-acting reversible contraception (LARC): Intrauterine device and implant. ACOG. https://www.acog.org/womens-health

Centers for Disease Control and Prevention. (2024). U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Centers for Disease Control and Prevention. https://www.cdc.gov/contraception/hcp/usmec/

Centers for Disease Control and Prevention. (2024). U.S. Selected Practice Recommendations for Contraceptive Use, 2024. Centers for Disease Control and Prevention. https://www.cdc.gov/contraception/hcp/usspr/

NU576 Unit 4 Seminar Notes: Contraception & Unintended Pregnancy Insights

Trussell, J. (2011). Contraceptive failure in the United States. Contraception, 83(5), 397–404. https://doi.org/10.1016/j.contraception.2011.01.021

World Health Organization. (2023). Family planning/contraception methods. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/family-planning-contraception

NU576 Unit 4 Seminar Notes. (2026). Contraception & unintended pregnancy insights.